Evidence map›Paper›PMID 35078352›Full record

ArticleOpen biology2022

A high-throughput assay for directly monitoring nucleolar rRNA biogenesis.

Carson J Bryant, Mason A McCool, Laura Abriola, Yulia V Surovtseva, Susan J Baserga

Abstract read
In one paragraph

Article in Open biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Ribosome biogenesis bottlenecks reveal vulnerabilities in cancer.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Roles of NOLC1 in cancers and viral infection.Journal of cancer research and clinical oncology · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carson J BryantDepartment of Molecular Biophysics and Biochemistry, Yale School of Medicine, 333 Cedar Street, New Haven, CT, USA.ORCID 0000-0002-7475-875X
Mason A McCoolDepartment of Molecular Biophysics and Biochemistry, Yale School of Medicine, 333 Cedar Street, New Haven, CT, USA.ORCID 0000-0001-7834-0927
Laura AbriolaYale Center for Molecular Discovery, Yale University, West Haven, CT, USA.ORCID 0000-0002-7304-6531
Yulia V SurovtsevaYale Center for Molecular Discovery, Yale University, West Haven, CT, USA.ORCID 0000-0001-6079-9246
Susan J BasergaDepartment of Molecular Biophysics and Biochemistry, Yale School of Medicine, 333 Cedar Street, New Haven, CT, USA.ORCID 0000-0002-7731-8629

Funding

Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
Novel regulatory networks driving human ribosome biogenesisR35GM131687 · NIGMS · YALE UNIVERSITY · PI Susan J Baserga · 2019 to 2026
$5.1M
CRK regulation of ribosome biogenesis and craniofacial developmentF31DE030332 · NIDCR · YALE UNIVERSITY · PI MCCOOL, MASON · 2020 to 2022
$108k
NIDCR NIH HHS F31 DE030332NIGMS NIH HHS R35 GM131687NIGMS NIH HHS T32 GM007223
6 · The paper itself

Abstract

Studies of the regulation of nucleolar function are critical for ascertaining clearer insights into the basic biological underpinnings of ribosome biogenesis (RB), and for future development of therapeutics to treat cancer and ribosomopathies. A number of high-throughput primary assays based on morphological alterations of the nucleolus can indirectly identify hits affecting RB. However, there is a need for a more direct high-throughput assay for a nucleolar function to further evaluate hits. Previous reports have monitored nucleolar rRNA biogenesis using 5-ethynyl uridine (5-EU) in low-throughput. We report a miniaturized, high-throughput 5-EU assay that enables specific calculation of nucleolar rRNA biogenesis inhibition, based on co-staining of the nucleolar protein fibrillarin (FBL). The assay uses two siRNA controls: a negative non-targeting siRNA control and a positive siRNA control targeting RNA Polymerase 1 (RNAP1;

Indexed as

Cell NucleolusTranscription, GeneticNuclear ProteinsRNA, RibosomalNuclear ProteinsRNA, Ribosomalhigh-throughput screeningnucleoluspre-rRNA processingpre-rRNA transcriptionribosome biogenesisRNA polymerase 1

Identifiers

PMID35078352
PMCPMC8790372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.